Skip to main content
HR 4262 112th Congress House Health Administrative law and regulatory procedures Administrative remedies Business records Consumer affairs Department of Health and Human Services Drug safety, medical device, and laboratory regulation Food and Drug Administration (FDA) Government information and archives Health information and medical records Licensing and registrations Manufacturing Product safety and quality Retail and wholesale trades User charges and fees

Cosmetics Safety Enhancement Act of 2012

Introduced: March 26, 2012 Introduced by: Pallone, Frank Democratic · New Jersey See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 30, 2012
Referred to the Subcommittee on Health.
Mar 26, 2012
Introduced in House
Mar 26, 2012
Referred to the House Committee on Energy and Commerce.
 Plain-English summary Congressional Research Service

Cosmetics Safety Enhancement Act of 2012 - Amends the the Federal Food, Drug, and Cosmetic Act to require the registration of cosmetic products and cosmetic manufacturing facilities, including, for each product: (1) a unique facility identifier, (2) every product's brand name, and (3) product ingredients. Sets registration fees.

Requires a cosmetic manufacturer: (1) before the introduction into interstate commerce of a cosmetic product, to establish a file containing scientific evidence substantiating the product's safety; (2) to report any serious adverse event information received that is associated with the use of a cosmetic product; and (3) maintain records concerning any cosmetic product that may be adulterated, misbranded, or otherwise in violation of the Act, including all records relating to cosmetic product safety substantiation or relating to serious adverse event reports.

Deems a cosmetic product adulterated if its manufacture, packing, or holding do not conform to current good manufacturing practice regulations.

Provides each manufacturer with an opportunity to cease distribution and recall of a cosmetic product if it is determined that there is a reasonable probability that the product is adulterated and the use of, or exposure to, such product will cause serious adverse health consequences or death to humans. Permits the issuance of an order requiring a recall if there is not a voluntary recall of an adulterated product.

What's happening now March 30, 2012

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2